Comments
Loading...
Climb Bio (CLYM) Forecast
NewsEarningsClimb Bio (CLYM) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Climb Bio Stock Price, Quotes and Forecasts | NASDAQ:CLYM | Benzinga
Explore Climb Bio stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CLYM.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Climb Bio (CLYM) stock?
You can purchase shares of Climb Bio (NASDAQ:CLYM) through any online brokerage.
Who are Climb Bio (CLYM) competitors?
Other companies in Climb Bio’s space includes: Zura Bio (NASDAQ:ZURA), Macrogenics (NASDAQ:MGNX), Anixa Biosciences (NASDAQ:ANIX), Galectin Therapeutics (NASDAQ:GALT) and OncoCyte (NASDAQ:OCX).
What is the forecast, or price target, for Climb Bio (CLYM) stock?
There is no analysis for Climb Bio to provide a consensus price target.
What is the current price for Climb Bio (CLYM)?
The stock price for Climb Bio (NASDAQ: CLYM) is $1.275 last updated April 14, 2025 at 3:07 PM EDT.
Does Climb Bio (CLYM) pay a dividend?
There are no upcoming dividends for Climb Bio.
When is Climb Bio (NASDAQ:CLYM) reporting earnings?
Climb Bio’s Q1 earnings are confirmed for Wednesday, May 14, 2025.
Is Climb Bio (CLYM) going to split?
There is no upcoming split for Climb Bio.
What sector and industry does Climb Bio (CLYM) operate in?
Climb Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.